Asston Pharmaceuticals Ltd. Announces Extraordinary General Meeting on 28th April, 2026

Asston Pharmaceuticals Ltd. has announced an Extraordinary General Meeting to be held on 28th April, 2026. The meeting will be conducted through 'Vide Conferencing' or 'Other Audio Visual Means'. The Company has arranged for an e-voting facility for its members and the cut-off date for determining the eligibility to vote has been fixed as April 17th, 2026. The meeting will transact two main businesses: the appointment of M/s Panchal SK & Associates as statutory auditors and the regularization of Mr. Yogesh Prakash Supekar as a Non-Executive Non-Independent Director.